Cancer Center Information Systems is a Shared Resource providing Integrated Information systems In support of clinical and basic sdence biomedical research. The resource provides infrastructure, personnel, technical support, assistance and consultation In four areas - networks, databases, servers and web applications. The goal ofthe resource Is to provide comprehensive computational support to enable researchers to use technology In the most efficient manner possible to accomplish their research goals. Cancer Center Information Systems is direded by Robert P. Annechiarico, under the administrative supervision of Dr. Stephen L. George, Director of Blostatisfics. In addifion to Mr. Anriechiarico, CCIS has 19 full time staff positions. The resource provides database and applications development, web site support, server support and desktop support for 54 servers (virtual and stand-alone, more than doubling since the last renewal) and for over 1000 users. In addition to network server support, CCIS supports large scale servers and software, as well as high performance computational platforms, forthe Biostatistics Shared Resource and the Bioinformatics Shared Resource. This group supports the Informatics needs of a variety of research areas and programs. Support for the SPORES in Brain and Breast Cancer, the Cancer Genetics Network and the Protocol Office represent some ofthe larger efforts. CCIS is working closely with the Duke Health Technology Solufions, the Duke Translational Medicine Institute, and the Institute for Genome Sciences and Policy to integrate clinical data with research data. Support for the resource is provided through a combination of grant support, chargeback and institutional funding. At the national level, CCIS has been a leader in the development of software tools and standards within the caBIG program, contributing to several cornerstone applications and projects.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Adams, Rebecca N; Mosher, Catherine E; Blair, Cindy K et al. (2015) Cancer survivors' uptake and adherence in diet and exercise intervention trials: an integrative data analysis. Cancer 121:77-83
Pruszynski, Marek; Koumarianou, Eftychia; Vaidyanathan, Ganesan et al. (2014) Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling. J Nucl Med 55:650-6
Batinic-Haberle, Ines; Tovmasyan, Artak; Roberts, Emily R H et al. (2014) SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways. Antioxid Redox Signal 20:2372-415
Sachdeva, Mohit; Mito, Jeffrey K; Lee, Chang-Lung et al. (2014) MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes. J Clin Invest 124:4305-19
Tovmasyan, Artak; Carballal, Sebastian; Ghazaryan, Robert et al. (2014) Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents. Inorg Chem 53:11467-83
Azrad, Maria; Demark-Wahnefried, Wendy (2014) The association between adiposity and breast cancer recurrence and survival: A review of the recent literature. Curr Nutr Rep 3:9-15
Blair, Cindy K; Madan-Swain, Avi; Locher, Julie L et al. (2013) Harvest for health gardening intervention feasibility study in cancer survivors. Acta Oncol 52:1110-8
Mito, Jeffrey K; Min, Hooney D; Ma, Yan et al. (2013) Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma. J Pathol 229:132-40
Pruszynski, Marek; Koumarianou, Eftychia; Vaidyanathan, Ganesan et al. (2013) Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody. Nucl Med Biol 40:52-9
Hover, Bradley M; Loksztejn, Anna; Ribeiro, Anthony A et al. (2013) Identification of a cyclic nucleotide as a cryptic intermediate in molybdenum cofactor biosynthesis. J Am Chem Soc 135:7019-32

Showing the most recent 10 out of 161 publications